Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Impact of Infusion Rate on the Early Engraftment Following Allogeneic Intra Bone Marrow Infusion of Hematopoietic Stem Cells in a Canine DLA-Identical Reduced Intensity Transplantation Model

Stephanie Schaefer, Juliane Werner, Sandra Lange, PhD, Katja Neumann, Christoph Machka, Hugo murua Escobar, PhD, Catrin Roolf, PhD, Gudrun Knuebel, Iris Lindner, PhD, Heike Vogel, Mathias Freund, Christian Junghanss, MD

Blood (2015) 126 (23): 5406.

https://doi.org/10.1182/blood.V126.23.5406.5406

Published: 2015

Journal Articles

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Blood (2014) 124 (21): 43.

https://doi.org/10.1182/blood.V124.21.43.43

Published: 2014

Journal Articles

Engraftment Effects of Intra Bone Marrow Compared to Intravenous Transplantation of Allogeneic Hematopoietic Stem Cells Following a Reduced Intensity Conditioning in a DLA-Identical Canine Littermate Model

Juliane Werner, Stephanie Schaefer, Sandra Lange, Christoph Machka, Gudrun Knuebel, Anett Sekora, Catrin Roolf, Hugo Murua Escobar, Heike Vogel, Iris Lindner, Mathias Freund, MD, Christian Junghanss, MD

Blood (2014) 124 (21): 1089.

https://doi.org/10.1182/blood.V124.21.1089.1089

Published: 2014

Journal Articles

Newly Synthesized Indolylmalemide PDA-66 and Its Derivates Induce Antiproliferative Effects In Acute Lymphoblastic Leukemia

Catrin Roolf, Christin Kretzschmar, Tina-Susann Langhammer, Anett Sekora, Anahit Pews-Davtyan, Matthias Beller, Arndt Rolfs, Mathias Freund, Christian Junghanss

Blood (2013) 122 (21): 4932.

https://doi.org/10.1182/blood.V122.21.4932.4932

Published: 2013

Journal Articles

PI3K/Akt Signaling Interacts With Wnt/β-Catenin Signaling But Does Not Induce An Accumulation Of β-Catenin In The Nucleus Of Acute Lymphoblastic Leukemia Cell Lines

Tina-Susann Langhammer, Catrin Roolf, Saskia Krohn, Christin Kretzschmar, Rayk Huebner, Arndt Rolfs, Mathias Freund, Christian Junghanss

Blood (2013) 122 (21): 4886.

https://doi.org/10.1182/blood.V122.21.4886.4886

Published: 2013

Journal Articles

Polymorphism nt7778G/T In Mitochondrial ATP8 Gene Promotes Protective Effect On Reactive Oxygen Species Level In Murine Hematopoietic Cells During Aging

Christin Kretzschmar, Catrin Roolf, Katrin Timmer, Gudrun Knübel, Anett Sekora, Sarah Müller, Markus Tiedge, Simone Baltrusch, Rüdiger Köhling, Saleh Ibrahim, Mathias Freund, Christian Junghanss

Blood (2013) 122 (21): 1196.

https://doi.org/10.1182/blood.V122.21.1196.1196

Published: 2013

Journal Articles

Factors Influencing Complete Remission (CR) Rate in Patients ≥ 60 Years with Acute Myeloid Leukemia (AML): Report From the German AML Intergroup Study

Blood (2012) 120 (21): 128.

https://doi.org/10.1182/blood.V120.21.128.128

Published: 2012

Journal Articles

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Blood (2012) 120 (10): 2032–2041.

https://doi.org/10.1182/blood-2011-12-399287

Published: 2012

Includes: Supplemental data

Journal Articles

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolf-Dieter Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer

Blood (2012) 120 (9): 1868–1876.

https://doi.org/10.1182/blood-2011-09-377713

Published: 2012

Includes: Supplemental data

Journal Articles

Overall Outcome of Relapsed Acute Lymphoblastic Leukemia Can Be Improved by Stem Cell Transplantation and Early Treatment in Stage of Molecular Relapse

Nicola Goekbuget, MD, Daniel Stanze, MD, Renate Arnold, Monika Brueggemann, MD, Rainer Fietkau, MD, Mathias Freund, MD, Arnold Ganser, MD, Wolf-Dieter Ludwig, Georg Maschmeyer, MD, Thorsten Raff, MD, Harald Rieder, MD, Eckhard Thiel, Hubert Serve, MD, Michael Kneba, MD, Dieter Hoelzer, MD

Blood (2011) 118 (21): 250.

https://doi.org/10.1182/blood.V118.21.250.250

Published: 2011

Journal Articles

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Dietger Niederwieser, MD, Leo F Verdonck, Jan J Cornelissen, MD PhD, Michael Cross, PhD, Rainer Krahl, MD, Thoralf Lange, Vladan Vucinic, Georg Franke, MD, Haifa K. Al-Ali, MD, Gert Ossenkoppele, MD, PhD, Georg Maschmeyer, MD, Gottfried Doelken, MD, Mathias Freund, MD, Norma Peter, Marc Boogaerts, MD, PhD, Alois Gratwohl, MD, Harry C. Schouten, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2011) 118 (21): 2030.

https://doi.org/10.1182/blood.V118.21.2030.2030

Published: 2011

Journal Articles

Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL),

Michael Schmitt, Rudolf Trenschel, MD, Herbert G. Sayer, MD, PhD, Catarina Schneider, Aenne Glass, Inken Hilgendorf, Anne Treschl, MD, Christian Junghanss, MD, Kersten Borchert, Michael Koenigsmann, Jochen Casper, MD, Dietrich Beelen, Mathias Freund, Christoph Kahl

Blood (2011) 118 (21): 4106.

https://doi.org/10.1182/blood.V118.21.4106.4106

Published: 2011

Journal Articles

Expression of RHAMM and WT1 As Well As T Cell Responses to These Antigens Before and After Allogeneic Stem Cell Transplantation in Patients with Leukemia

Rosaely Casalegno-Garduño, Claudia Meier, Jiju Mani, Kersten Borchert, Inken Hilgendorf, Yvonne Gross, Anna Filipowska, Dirk Koczan, Alf Spitschak, Michael Linnebacher, Anita Schmitt, Jochen Greiner, MD, Mathias Freund, Brigitte M Püutzer, Michael Schmitt

Blood (2011) 118 (21): 4315.

https://doi.org/10.1182/blood.V118.21.4315.4315

Published: 2011

Journal Articles

Use of the G-CSF Biosimilar Ratiograstim® to Mobilize Peripheral Stem Cells in Healthy Donors for Allogeneic Stem Cell Transplantation

Michael Schmitt, Diestel Lena, Catarina Schneider, Xun Xu, Kersten Borchert, Dietrich Gläser, Inken Hilgendorf, Robert Scheuerlein, Mathias Freund, Anita Schmitt

Blood (2011) 118 (21): 1928.

https://doi.org/10.1182/blood.V118.21.1928.1928

Published: 2011

Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Blood (2011) 117 (7): 2121–2128.

https://doi.org/10.1182/blood-2010-06-290080

Published: 2011

Journal Articles

Intra-Bone Marrow Transplantation of CD34+ Enriched Grafts Following a Non-Myeloablative Conditioning Allows Successful Engraftment In DLA-Identical Canine Litters.

Anne Knueppel, Doreen Killian, Sandra Lange, Heike Vogel, Iris Lindner, Simone Dunkelmann, Friedrich Prall, Mathias Freund, Gudrun Knuebel, Anett Sekora, Christian Junghanss

Blood (2010) 116 (21): 3711.

https://doi.org/10.1182/blood.V116.21.3711.3711

Published: 2010

Journal Articles

Lymphocyte Subsets In Chronic Gvhd – a Key Role for B Cells?

Inken Hilgendorf, Brigitte Mueller-Hilke, Guenther Kundt, Ernst Holler, Petra Hoffmann, Mathias Edinger, Mathias Freund, Daniel Wolff

Blood (2010) 116 (21): 2311.

https://doi.org/10.1182/blood.V116.21.2311.2311

Published: 2010

Journal Articles

Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients.

Hannes Wandt, MD, Kerstin Schaefer-Eckart, MD, Bettina Pilz, Markus Thalheimer, MD, Anthony D Ho, MD, PhD, Markus Schaich, MD, Martin Kaufmann, MD, Walter E. Aulitzky, MD, Mathias Haenel, MD, Regina Herbst, MD, Gottfried Doelken, MD, Anne Friederike Klenner, MD, Mathias Freund, MD, Christian Junghanss, MD, Gerhard Ehninger, MD

Blood (2009) 114 (22): 20.

https://doi.org/10.1182/blood.V114.22.20.20

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Blood (2009) 114 (22): 51.

https://doi.org/10.1182/blood.V114.22.51.51

Published: 2009

Journal Articles

The Dual PI3K and mTOR Kinase Inhibitor NVP-BEZ235 Induces Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells and Potentiates the Cytotoxicity of Dexamethasone, Cytarabine and Doxorubicin.

Catrin Schult, Meike Dahlhaus, Anett Sekora, Sandra Lange, Mathias Freund, MD, Christian Junghanss, MD

Blood (2009) 114 (22): 4115.

https://doi.org/10.1182/blood.V114.22.4115.4115

Published: 2009

NARROW

Impact of Infusion Rate on the Early Engraftment Following Allogeneic Intra Bone Marrow Infusion of Hematopoietic Stem Cells in a Canine DLA-Identical Reduced Intensity Transplantation Model

Autologous Followed By Allogeneic Versus Tandem-Autologous Stem Cell Transplant in Newly Diagnosed FISH-del13q Myeloma

Engraftment Effects of Intra Bone Marrow Compared to Intravenous Transplantation of Allogeneic Hematopoietic Stem Cells Following a Reduced Intensity Conditioning in a DLA-Identical Canine Littermate Model

Newly Synthesized Indolylmalemide PDA-66 and Its Derivates Induce Antiproliferative Effects In Acute Lymphoblastic Leukemia

PI3K/Akt Signaling Interacts With Wnt/β-Catenin Signaling But Does Not Induce An Accumulation Of β-Catenin In The Nucleus Of Acute Lymphoblastic Leukemia Cell Lines

Polymorphism nt7778G/T In Mitochondrial ATP8 Gene Promotes Protective Effect On Reactive Oxygen Species Level In Murine Hematopoietic Cells During Aging

Factors Influencing Complete Remission (CR) Rate in Patients ≥ 60 Years with Acute Myeloid Leukemia (AML): Report From the German AML Intergroup Study

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

Overall Outcome of Relapsed Acute Lymphoblastic Leukemia Can Be Improved by Stem Cell Transplantation and Early Treatment in Stage of Molecular Relapse

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL),

Expression of RHAMM and WT1 As Well As T Cell Responses to These Antigens Before and After Allogeneic Stem Cell Transplantation in Patients with Leukemia

Use of the G-CSF Biosimilar Ratiograstim® to Mobilize Peripheral Stem Cells in Healthy Donors for Allogeneic Stem Cell Transplantation

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Intra-Bone Marrow Transplantation of CD34+ Enriched Grafts Following a Non-Myeloablative Conditioning Allows Successful Engraftment In DLA-Identical Canine Litters.

Lymphocyte Subsets In Chronic Gvhd – a Key Role for B Cells?

Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients.

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

The Dual PI3K and mTOR Kinase Inhibitor NVP-BEZ235 Induces Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells and Potentiates the Cytotoxicity of Dexamethasone, Cytarabine and Doxorubicin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only